Laboratory Director
Women's Health ABMGG board certified
Confirmed live in the last 24 hours
Natera

1,001-5,000 employees

Global leader in personalized genetic testing
Company Overview
Natera stands as a global leader in cell-free DNA testing, with a dedicated focus on oncology, women’s health, and organ health, aiming to integrate personalized genetic testing into standard healthcare practices. The company's competitive advantage lies in its proprietary cfDNA technology platform, which has been validated by over 100 peer-reviewed publications for its high accuracy, and its diverse team of experts from various fields. Natera's commitment to industry leadership is evident in its ISO 13485-certified and CAP-accredited laboratories, and its proactive stance against cyber crimes, ensuring a secure and innovative work environment.
Biotechnology

Company Stage

N/A

Total Funding

$1.2B

Founded

2004

Headquarters

Austin, Texas

Growth & Insights
Headcount

6 month growth

5%

1 year growth

10%

2 year growth

21%
Locations
Austin, TX, USA
Experience Level
Entry
Junior
Mid
Senior
Expert
CategoriesNew
Biology & Biotech
Requirements
  • MD/DO and/or PhD in genetics or related field required
  • ABMGG board certified- in Clinical Cytogenetics and/or Molecular Genetics, ABP board-certified in Molecular Genetic Pathology, or equivalent doctoral-level board required
  • Current California laboratory director license as a Clinical Genetic Molecular Biologist or Clinical Cytogeneticist required
  • Current Certificate of Qualification in Genetic Testing from the NYS CLEP required
  • 5 or more years of experience in a CLIA-certified clinical laboratory setting analyzing, interpreting and reporting clinical genetic/genomic data
  • Knowledge of CAP, CLIA, and applicable state regulations; including but not limited to California, and New York state regulations
  • Management experience required
  • Excellent written and oral communication skills
  • Experience leading a laboratory offering prenatal screening and oncology testing and evaluating, interpreting, and reporting out NGS and microarray data
  • Familiarity with next-generation sequencing, and/or knowledge of advanced methods of copy number detection
  • Strong background in human and medical genetics, and oncology with a familiarity of online human genomics
  • Understanding of statistical measures utilized in genetic testing and screening
Responsibilities
  • Review, approve, and sign-out reports for a variety of clinical molecular/cytogenetic and/or oncologic results, including NGS and other methodologies
  • Oversee the review of genetic and variant data: interpret NGS results in the context of medical literature, online variant databases and other references along with relevant patient demographic data
  • Provide clinical and technical support for genetic counselors and other laboratory personnel
  • Set standards for laboratory testing and acceptable levels of analytic performance and ensure these are maintained
  • Analyze lab data, contribute to or write publications for high-quality scientific journals
  • Test reports include pertinent information for test interpretation
  • Availability for consultation concerning test results and the interpretation of those results as they relate to specific patient conditions
  • Appropriate test method selection
  • Adequate method verification to determine the accuracy and precision of the test
  • Enrollment of the laboratory in a CMS-approved proficiency testing (PT) program for the test performed
  • PT samples are tested in accordance with the CLIA requirements
  • PT results are returned within the time frames established by the PT program
  • PT reports are reviewed by the appropriate staff
  • Corrective action plans are followed when PT results are found to be unacceptable or unsatisfactory
  • Quality assessment and quality control programs are established and maintained
  • Acceptable analytical test performance is established and maintained for each test system